Drugs & TargetsFree Olaparib receives FDA approval for HRR gene-mutated metastatic castration-resistant prostate cancer May 22, 2020Vol.46 No.21
Drugs & TargetsFree BRACAnalysis CDx receives approval as companion diagnostic for Lynparza in mCRPC indication May 22, 2020Vol.46 No.21
Drugs & TargetsFree Karyopharm submits sNDA for Xpovio as treatment for multiple myeloma after at least one prior line of therapy May 22, 2020Vol.46 No.21
Clinical RoundupFree Flatiron Health, Foundation Medicine, Genentech to launch novel prospective lung cancer clinical study May 22, 2020Vol.46 No.21
Clinical RoundupFree Advanced prostate cancer rates continued to rise after USPSTF guideline change May 22, 2020Vol.46 No.21
Clinical RoundupFree Study: Text messages are ineffective reminders to maintain AI regimens May 22, 2020Vol.46 No.21
FreeFunding Opportunities Hope Foundation announces John Crowley award for statistical excellence in cancer clinical trials May 22, 2020Vol.46 No.21
FreeIn Brief UChicago Medicine receives $10M to develop a center for cellular therapy May 22, 2020Vol.46 No.21
FreeIn Brief Peter C. Adamson named global development therapeutic area head of oncology and pediatric innovation at Sanofi May 22, 2020Vol.46 No.21
FreeIn Brief Vassiliki Papadimitrakopoulou named clinical development leader of Pfizer Oncology May 22, 2020Vol.46 No.21
